SecProbe.io

CORRESP
1
filename1.htm

    January
    26, 2024

    VIA
    EDGAR

    Tyler
Howes/ Jason Drory

    Securities
and Exchange Commission

    Division
of Corporation Finance

    100
F. Street, N.E.

    Washington,
    D.C. 20549

    Re:
BioLingus (Cayman) Limited the “Company”)

    Registration
    Statement on Form F-1

    File
    No. 333-273093

Ladies
and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), and as representatives of the several
underwriters of the Company’s proposed public offering, we wish to advise you that we hereby join with the Company’s request
that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 5:00
p.m., Eastern Time, on January 31, 2024, or as soon thereafter as is practicable.

Pursuant
to Rule 460 under the Securities Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed
to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of
the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

We,
the undersigned, have complied and will continue to comply, and we have been informed by the participating underwriters and dealers that
they have complied and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

    Very
    truly yours,

    Univest
    Securities, LLC

    By:
    /s/
    Edric Guo

    Name:
    Edric
    Guo

    Title:
    Chief
    Executive Officer